Drug intelligence / Profile preview

Td-IMMUN

Development stage: Unknown
Lead developer: AJ Vaccines
Modality: Vaccines & Immunotherapeutics
Administration: Intramuscular

Overview

Td-IMMUN is a bivalent vaccine containing tetanus and diphtheria toxoids, indicated for active immunization against tetanus and diphtheria in individuals aged five years and older. It is used for both primary vaccination series and booster doses. The vaccine is manufactured by AJ Vaccines A/S and distributed in the German market by Astro Pharma as an alternative to the Td-pur vaccine. It is administered via intramuscular injection and induces the production of specific antitoxins to provide protection against infections caused by *Clostridium tetani* and *Corynebacterium diphtheriae*.

Brand names: Td-IMMUN
Other names: Td-IMMUN-ASTRO-vaccine-IM-tetanus/diphtheria (Td) or general vaccination

Targets

TT (Tetanus toxoid)

Beyond the preview

Go deeper on Td-IMMUN.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Td-IMMUN.

Explore the full profile